Patent directory · USPTO A61K / A61P
Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human Serv”
1,157 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,157 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9175062
Human soluble receptor for advanced glycation end products (sRAGE), methods of preparing human sRAGE, and treatment methods using sRAGE
granted -
US 9168297
Regulation of skin pigmentation by neuregulin-1 (NRG-1)
granted -
US 9169297
Subgenomic replicons of the flavivirus dengue
granted -
US 9168291
β-mannosylceramide and stimulation of NKT cell anti-tumor immunity
granted -
US 9169296
Expression and assembly of human group C rotavirus-like particles and uses thereof
granted -
US 9168266
Hybrid diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
granted -
US 9169182
Chrysophaentin analogs that inhibit FtsZ protein
granted -
US 9163258
Method for the treatment of obesity
granted -
US 9151762
Identification of DSG-3 as a biomarker for the detection of metastasis in lymph nodes
granted -
US 9150926
Diagnosis and treatment of adrenocortical tumors using human microRNA-483
granted -
US 9150644
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
granted -
US 9144604
Vaccine for Shigella
granted -
US 9140687
Renal cell carcinoma biomarkers
granted -
US 9139595
Biologically active macrolides, compositions, and uses thereof
granted -
US 9133480
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites
granted -
US 9133478
Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences inserted into the intergenic regions between essential genes
granted -
US 9128080
Modified T cell receptors and related materials and methods
granted -
US 9127056
Monospecific and bispecific human monoclonal antibodies targeting insulin-like growth factor II (IGF-II)
granted -
US 9114102
Method of inhibiting ABCG2 and related treatments
granted -
US 9115371
Reduction of TGF beta signaling in myeloid cells in the treatment of cancer
granted -
US 9101601
Methods of treating or preventing insulin resistance and associated diseases and conditions
granted -
US 9101600
Compounds as RORγt modulators and uses thereof
granted -
US 9096653
Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia
granted -
US 9084820
Magnetic microstructures for magnetic resonance imaging
granted